1 Issazadeh-Navikas Group, BRIC Research Groups, BRIC, Københavns Universitet2 Issazadeh-Navikas Group, BRIC Research Groups, BRIC, Københavns Universitet
Anticancer immunotherapies are highly desired. Conversely, unwanted inflammatory or immune responses contribute to oncogenesis, tumor progression, and cancer-related death. For non-immunogenic therapies to inhibit tumor growth, they must promote, not prevent, the activation of anticancer immune responses. Here, the central immunoregulatory role of brain-specific stromal cells and neurons as well as their ability to maintain an immunological balance and prevent the development of glioblastoma is discussed.